Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117365432 | 11736543 | 2 | F | 201012 | 20160804 | 20151113 | 20160907 | PER | US-JNJFOC-20151002688 | JANSSEN | 59.91 | YR | A | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117365432 | 11736543 | 1 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | U | U | 0 | INJECTION | ||||||||
| 117365432 | 11736543 | 2 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | U | U | 20635 | INJECTION | ||||||||
| 117365432 | 11736543 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 0 | 500 | MG | TABLETS | ||||||
| 117365432 | 11736543 | 4 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 0 | 250 | MG | TABLETS | ||||||
| 117365432 | 11736543 | 5 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 0 | 500 | MG | TABLETS | ||||||
| 117365432 | 11736543 | 6 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 20634 | 250 | MG | TABLETS | ||||||
| 117365432 | 11736543 | 7 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | N | N | 0 | LYOPHILIZED POWDER | ||||||||
| 117365432 | 11736543 | 8 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | U | U | 0 | 250 | MG | UNSPECIFIED | ||||||
| 117365432 | 11736543 | 9 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | U | U | 20634 | 500 | MG | UNSPECIFIED | ||||||
| 117365432 | 11736543 | 10 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Unknown | U | 0 | 400 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117365432 | 11736543 | 1 | Pneumonia |
| 117365432 | 11736543 | 2 | Infection |
| 117365432 | 11736543 | 3 | Pneumonia |
| 117365432 | 11736543 | 4 | Pneumonia |
| 117365432 | 11736543 | 5 | Infection |
| 117365432 | 11736543 | 6 | Infection |
| 117365432 | 11736543 | 7 | Plasma cell myeloma |
| 117365432 | 11736543 | 8 | Product used for unknown indication |
| 117365432 | 11736543 | 9 | Product used for unknown indication |
| 117365432 | 11736543 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117365432 | 11736543 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117365432 | 11736543 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117365432 | 11736543 | 3 | 200705 | 200806 | 0 | |
| 117365432 | 11736543 | 4 | 201010 | 201012 | 0 | |
| 117365432 | 11736543 | 5 | 200705 | 200806 | 0 | |
| 117365432 | 11736543 | 6 | 201010 | 201012 | 0 | |
| 117365432 | 11736543 | 7 | 201102 | 0 | ||
| 117365432 | 11736543 | 8 | 201301 | 0 | ||
| 117365432 | 11736543 | 9 | 201206 | 0 | ||
| 117365432 | 11736543 | 10 | 200906 | 0 |